New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
So Glad We Found Gladskin Eczema Cream - LimByLim
Antibiotics | Free Full-Text | Endolysin, a Promising Solution against Antimicrobial Resistance
Antibiotics | Free Full-Text | Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application
Micreos (@Micreos) / X
Micreos sidesteps antibiotic resistance, targeting superbugs with $37M for endolysin | 2021-10-04 | BioWorld
BBC Two - Trust Me, I'm a Doctor, Series 6, Episode 2 - Could enzymes called endolysins ease eczema symptoms and offer an alternative to antibiotics?
Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics
New Gladskin Eczema Cream Is Based on Three Billion Years of Nature's Work
Targeted Endolysin Whitepapers | Gladskin
Micreos Initiates P-I/IIa Study Evaluating XZ.700 as the World's First Endolysin Therapy for Atopic Dermatitis
Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis - Microbiome Times Magazine
Viruses | Free Full-Text | The Advantages and Challenges of Using Endolysins in a Clinical Setting
Antibiotics | Free Full-Text | Endolysin, a Promising Solution against Antimicrobial Resistance
Targeted Endolysin Whitepapers | Gladskin
Endolysins Vs MRSA
Investigating the potential of endolysin loaded chitosan nanoparticles in the treatment of pneumococcal pneumonia - ScienceDirect
Western blot analysis of endolysin accumulation in transgenic lines.... | Download Scientific Diagram
NEW STUDY: Gladskin ingredient Staphefekt™ found to significantly redu
Pharmaceuticals | Free Full-Text | Antibacterial and Anti-Biofilm Efficacy of Endolysin LysAB1245 against a Panel of Important Pathogens
Antibiotics | Free Full-Text | Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
Targeted Endolysin Whitepapers | Gladskin
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
